MEDIUM conviction · 110 dossiers

Identity-software momentum continuation: OKTA gapped to a 52-week high on a Q1 FY27 beat and FY27 guide raise (2026-05-29). Theme classifier still ACCELERATING (0.78), but the catalyst is now behind it the entire sell-side PT-raise cluster…

A narrative accelerating on FUNDAMENTALS: Q1 FY27 product rev $1.33B +34% (re-accel from +30%), RPO +38%, FY27 guide raised to $5.84B, Cortex Code fastest-ramping product ever on the $200M Anthropic deal. Driver is theme acceleration the…

BTC-miner→AI-infra pivot structurally de-risked: backlog ~$31B after Polaris Forge 3 ($7.5B/15yr take-or-pay, 300MW, capacity past 1.2GW) on top of CoreWeave 400MW (~$11B) and Polaris Forge 2 ($5B). Neocloud theme ACCELERATING; stock…

ASML is the cleanest second-derivative on the AI-capex super-cycle: EUV monopoly, CEO's "supply-limited market for quite a while" framing (5/20), High-NA first product data on logic AND DRAM later in 2026, JPM Overweight PT $2,200 (6/3).…

Q2 FY26 (2026-06-03) printed a monster $30B AI bookings vs $10.8B shipped (2.8x book-to-bill), $100B+ FY27 AI guide but AVGO sold the news (-12% on 2026-06-04) and kept falling into a rate-driven risk-off. Fundamentals ACCELERATING, tape…

BTC-miner→AI-neocloud pivot resolved bull: 5-yr $3.4B Microsoft AI-cloud contract + $3.65B investment-grade GPU financing (closed 6/1) + Dell $1.6B Blackwell supply killed both the named-tenant and dilution gates. Theme ACCELERATING, PTs…

Optical-AI picks-and-shovels: the post-print -8.45% sell-the-news is fully reversed LITE reclaimed its pre-print high on a 2026-06-01 +7% signal bar at $866.97, riding Nasdaq-100 inclusion and the 2026-06-02 AI-chip rally to fresh records.…

Commercial-flywheel re-acceleration (Google Cloud Marketplace + Dell on-prem + multi-vertical deal cadence into June) plus Trump 'trusted partner' 60-day clock but price was rejected at the 200-DMA (2026-06-03) on a MATURING,…

Accelerating TL1A/I&I platform: SPY001 Part A de-risked UC (Robarts −9.2, p<0.0001); next leg is SPY002 "mid-2026" open-label Part A induction. Abivax obefazimod's Phase 3 malignancy signal (6/4) cleared an oral UC competitor and drove DB…

Specialty-foundry AI-recovery confirmed by the 2026-05-13 Q1 beat (op profit ~doubled, GM up, Q2 guide raised, +17%) but the catalyst is fully digested, sell-side caught up ($300–335 PTs), news dry 3 weeks, theme registry narrowed to one…

Optical ACCEL (0.90) cluster winner: Jensen optical-shift confirm + NVDA $1.9B stake, RSI 60.8 healthy, buy-the-pullback on a $405 — reclaim. Cleanest non-semi AI-infra expression; prior -8.3% exit warrants volume confirm.

Q1 FY27 binary cleared (~5/28); AI-capex demand printing harder (SpaceX-Google 110k-GPU deal 6/06, Oracle $100B capex 6/05) even as a 6/05 risk-off pulse and clustering AI-bubble warnings (Chamath 6/07) turn the tape two-sided. NVDA is the…

Legacy bitcoin miner re-rating into AI-datacenter landlord: AMD Rockdale lease contracted at 50MW/10yr/$311M, Q1 2026 booked $33.2M data-center revenue inside $167.22M total. Theme ACCELERATING and cluster-confirmed (IREN/Hut 8/TeraWulf),…

BASX data-center liquid-cooling narrative violently re-rated on the 2026-05-07 Q1 blowout rev +54% YoY, FY guide doubled to 40-45%, backlog +107% to $2.13B. Theme accelerating, but the binary already detonated (+53% in 30d), insiders sold…

Scandal-era behavioral-health operator turning operationally under new management: clean Q1 (rev +7.6%, acute psych +14%, reported 2026-04-29), FY guide raised to $3.37–3.45B, two clustered Buy upgrades (UBS $31 Apr, Jefferies $30 Jun 3).…

Memory-capex pick-and-shovel re-rating + pending all-stock Veeco merger drove ACLS +83% in 3mo to ~$167; DRAM is now 32% of Q1 shipments and HBM4 lifts implant intensity. But FY26 revenue is guided FLAT, DCF ~$92, price sits only ~8% under…

Analog cyclical-trough-is-in + AI-power optionality (Empower $1.5B) narrative already fired: Q2 beat ~2026-05-20 triggered 11+ PT hikes to $440–515 by 05-26. Binary is now in the rearview and sell-side has fully caught up late validated…

clonoSEQ MRD franchise inflecting to profitability as the narrative goes public Q1 MRD revenue +53% YoY (May 5), FY guide raised to $260–270M, positive adj-EBITDA/FCF targeted by year-end; ASCO/EHA data through Jun 14 validating the MRD…

Frac-sand legacy pivot re-rating into AI/data-center behind-the-meter power on the $840M Caterpillar 1.4GW genset deal plus an upgrade cluster (RJ Outperform $25 6/2, Citi $22). But the 6/2 breakout faded -8.6% on 6/5 as Goldman reaffirmed…

Pure-play EPC for hyperscaler gas-fired data-center power. Q1 FY27 (2026-06-04) confirmed the thesis hard revenue +50% to a record $291M, EPS $3.24 vs $2.33 est, EBITDA +79% but the binary is now consumed, backlog slipped QoQ to $2.8B…

Hospitality vertical-SaaS re-rating off a deep 2025 drawdown: 17th straight record quarter (Q4 rev $82.9M, EPS $0.63 vs $0.50), FY27 guide $365-370M with subscription +30%, and clustered analyst actions (Piper initiates $110, 2026-06-02)…

Semiconductor-IP royalty re-accel is now confirmed: Q1 (reported 2026-05-12) revenue +39% and variable royalties +67% YoY drove a near-2x re-rate to a $38.99 ATH plus PT hikes (Rosenblatt $38, Jefferies $35). Fundamentals ACCELERATING, but…

Data-center power-IC re-rate intact fundamentally, but the 2026-06-05 rate-hike scare (Nasdaq -3%) reversed ALGM from a fresh ~$54.40 high to $46.39 a ~15% failed-breakout drop, back to the $46 consensus PT. 86% cyclical book sells with…

Orexin sleep-medicine re-rate: Takeda's Phase 3 + FDA priority review validated the OX2R class, and Alkermes' alixorexton posted positive Phase 2 in both NT1 (Vibrance-1) and NT2 (Vibrance-2), with Phase 3 underway and an IH readout due Q4…

Legacy fuel-ethanol producer re-rated ~6x off a $0.92 low on a specialty-alcohol + Section 45Z tax-credit pivot. Q1 2026 (2026-05-06) was the first GAAP-profit quarter $0.05 EPS beat but shares fell 18% on the print. Sell-side now arriving…

Commodity-generics maker re-rating into specialty branded, biosimilars, and GLP-1 contract manufacturing. Q1 adj. EBITDA +19% and Specialty +23%, then June CREXONT Phase 4 data and a romidepsin FDA approval drove a +19% week to fresh…

AI-datacenter interconnect picks-and-shovels narrative accelerating: Q1 2026 orders hit a record $9.4B (book-to-bill 1.24), the $10.5B CommScope CCS deal (~$4.1B FY sales) closed in January, IT Datacom +80% YoY. Stock consolidating ~8%…

April sell-side stalemate broke bullish: Q1 (5/07) beat at $75.0M rev +13.4% and the desk cluster flipped to Strong Buy, then Citrini's ~5/29 long initiation ran ATEN to a fresh 52-wk high ($30.57 spot). AI-networking-adjacency narrative…

Argentina disinflation/reform turnaround accelerating, with BBAR a cluster-confirmed bank vehicle for a credit cycle off a near-zero base. Stock near 52-wk highs (~$20.6) after a near-triple off $7.76; loan-growth runway is the leg, but…

On-site-power-for-AI narrative ACCELERATING and cluster-confirmed: Oracle's up-to-2.8GW Project Jupiter (Apr 27) plus the Nebius $2.6B/328MW deal (May 20) re-rated Bloom to AI-infra supplier on a ~$20B backlog and a Q1 turn to GAAP profit.…

EMS arms-dealer to the AI buildout AC&C +41% YoY (liquid-cooling for AI data centers) + semi-cap recovery drove a FY26 guide raise to 9–10% on the 2026-04-29 print. Narrative accelerating, but the ~145% run to ~$88 is above the $78 avg PT…

Post-earnings-gap premium footwear brand re-rated ~+46% off the $33.45 May-13 low on a $250M accelerated buyback, a Kith capsule "brand heat" drop, and short-covering; now ~10% under the $54 ATH with the buyback bid set to settle by ~June…

Bitcoin-miner-to-AI pivot ratified by the May-14 Q1 beat ($188.9M rev, AI-cloud ARR ~$69M at +60% MoM, EBITDA flipped positive); analysts re-rated to $23–25 and shares ran ~$12→$20. Narrative accelerating, but the name is mid-pullback as…

Data-center-power order book vertical (Q1 orders +97% to $449.5M, b2b 2.2x, guide raised twice) and the $2.2B Thermon merger closed 2026-06-01, ~doubling scale to ~$1.5B combined revenue. Accelerating 2nd-order industrial-power narrative…

AI-networking picks-and-shovels narrative still accelerating after the 2026-04-27 Q1 blowout (rev +53% to $4.05B, FY26 guide raised $17B→$19B; CIBC $480/BMO $450 chasing) but the stock just reset ~21% from the $474 June-2 high to $372,…

Last big pure-play BTC miner re-rating on its AI/HPC neocloud pivot, but the May acceleration leg has stalled: the 2026-06-04 production update again showed no signed deal and shares fell into 2026-06-05. Theme rolling…

Post-CRL redemption arc largely complete: stock round-tripped $28.66→$91 high, now $72.62. Live leg is Cushing's second-approval optionality NDA resubmission announced 2026-05-27 (no new trials, PDUFA ~late 2026). Q1 missed (+4.9% YoY, net…

AI-enterprise cleanest structure: 6 rules incl rule 3 within-10%-of-high, RSI 56 healthy, $9B AI order book; Cisco Live 6/8-12 soft catalyst prefer $118-120 retest over a $128 chase.

Grid/T&D capex supercycle (data-center power + grid modernization) is the accelerating leg; CTOS is the laggard specialty-rental picks-and-shovels name re-rating on a Q1 beat-and-raise, clustered PT hikes to $11–13, and a new Sourcewell…

Freight-cycle inflection play: ~88k carrier authorities exited in 2023-24 and dry-van contract rates turned up again in April 2026, giving trough-earning Covenant heavy operating leverage to the recovery. Stock just tagged a 52-week high…

CGT cold-chain picks-and-shovels; the 2026 re-rate (FDA manufacturing flexibility + biotech-funding recovery + commercial CGT rev +26% YoY at the May 4 print) has largely played out. Spot ~$15.70 now sits ABOVE the $15.31 consensus PT…

Profitable AI-underwriting neobank: Q1 rev +47% to $158.4M, NI +101%, record-low 1.69% past-due (CashAI). Stock reclaimed the ~$244 post-Q1 pullback and pushed to ~$258, ~12% under the $293.90 high. But theme is MATURING seven desks now…

Cyclical analog/discrete recovery re-rated into an AI-server content story: Q1 beat (rev $405.5M +22% YoY, EPS $0.43 vs $0.34) plus a raised Q2 guide ($435M) drove a +15% two-day spike (6/01→6/03). The binary already resolved bullish now a…

Pure-play multi-price discount turnaround post-Family-Dollar divestiture. Q1 (May 28, 2026) beat-and-raise: comps +3.5%, adj EPS $1.74 (+38% YoY), GM +120bps, FY guide raised to $6.70–7.10. Stock gapped +18% to ~$113 and held ~$114.…

The narrative already paid out: gMG Phase 2 read positive (Sep-2025), CIDP CAPTIVATE hit an early Phase 3 GO (Mar-2026), sell-side fully caught up ($121 consensus PT, $16→$96 52-wk run) and a $719M raise at $81 closed Mar-12. Now…

Agentic-AI-beneficiary re-rating: Q1 beat + raised FY26 guide (2026-05-06) drove a one-week sell-side cluster ($175–200 PTs) and a May 4–8 rip alongside MU/RKLB. But the catalyst is a month stale and KeyBanc's 2026-06-03 $200 initiation…

Railcar-inspection microcap re-rated as an AI edge data-center/GPUaaS operator; the 2026-06-05 USD.AI $98.1M non-dilutive, off-balance-sheet facility funds the 2,304 B300 GPUs for the $176M Hydra Host contract, gutting the dilution bear…

CGM leader re-accelerating off a beaten-down base: the CONNECT trial (6/8) showing G7 cuts A1C 1.6% in Type 2 non-insulin patients opens a structural TAM, and the first OTC pediatric CGM clearance (6/12) plus an $85–95 analyst PT cluster…

De-risking BCR::ABL1 story: ELVN-001 Phase 1 ENABLE update hits an EHA oral June 11 (T-4) plus webcast 69% cumulative MMR (60/120mg) and 52% in asciminib-pretreated CML, no MTD, $462.6M cash into 1H-2029, Phase 3 ENABLE-2 launching…

Broadcaster-to-adtech pivot validated: Q1 (5/5) ATS/Smadex revenue +204% YoY to $154.55M, swing to $20.7M op income, EPS $0.13 vs -$0.53. Accelerating fundamental leg, but no 30-day catalyst and the TelevisaUnivision affiliation expiry…

Legacy EMS giant re-rating into an AI data-center power play: CPI segment +31% to $1.8B (Q4 FY26), spinning off Q1 CY2027 (SpinCo guide +65-75% FY27). Hard near-term catalyst: S&P 500 inclusion effective 2026-06-22. ~9% pullback to ~$152…

Probe-card HBM/advanced-packaging pick-and-shovel re-accelerating post-print: the 2026-06-05 Evercore upgrade to Outperform, PT $155 (~20% above the April $125–130 cluster), confirms the ~2026-05-06 Q1 guide held. Narrative ACCELERATING;…

GLJ's 2026-05-27 capitulation to a $315 Buy completed FSLR's re-rate from value-trap to policy-moated AI-power prime after the Q1 beat; solar theme ACCELERATING. But the catalysts already fired, price sits at the top Street PT ~18% above…

Picks-and-shovels sports-data toll-booth under the prediction-market boom; narrative accelerating since the June 10 Polymarket/Liga MX data deal, landing into the live World Cup (final ~July 19) volume surge. Q1 raised FY26 EBITDA guide to…

Silicon-photonics + quantum-foundry pivot accelerating: Keysight/Sivers/DOE-Genesis partnerships clustered 6/2–6/3 on top of a Q1 beat and first-ever dividend. Near-term cap is Mubadala's $1.91B block (5/27) supply overhang the clean leg…

Argentina reform trade reaccelerating: Milei's Oct-26 2025 midterm landslide plus May CPI at an 8-month low (2.1%, released June 11) revive the disinflation narrative. GGAL, the liquid large-cap bank proxy, has bounced ~35% off its $40…

GLP-1 reaccel guide (Q2 +25-28% YoY off Q1's +4% trough) now paired with a fresh peptides/longevity leg: new CMO hired 2026-06-04 (+7% day) and Canaccord $32 / Needham $35 PTs printed ABOVE spot. Real reaccel, but extended after a froth…

AR/smart-glasses display-silicon narrative broke a multi-year base to an all-time high ($24.19, 2026-06-03) after the +38% Q1 reaction and Baird's $10→$30 raise. ACCELERATING: WiseEye AI + LCoS + CPO inflections stacking, Q2 guided +10–13%…

BTC-miner→AI-compute re-rating is now live: ~2026-06-01 BUZZ HPC unveiled a 320 MW Greater Toronto AI gigafactory (100k+ GPUs, $660M ARR target by 2028) on $35M contracted ARR, triggering an analyst-raise cluster (B. Riley $8, Cantor $4.60…

Digital-MSK re-rate broke out: HNGE cleared the $62.18 Aug-2025 ATH to new highs (~$64, +29% in 30 days) on a fresh Canaccord PT raise (2026-06-04/05), confirming the post-Q1 momentum leg rather than topping. Accelerating, but extended,…

Equipment-rental roll-up in recovery (+55% off the $88.45 low to ~$137) on data-center/mega-project rental demand + the now-integrated H&E synergy ramp. Bellwether URI raised FY26 guidance (2026-04-23), confirming an ACCELERATING theme.…

Freight-cycle inflection accelerating truckload spot rates +23% off Q4 lows, OTRI past 14%, KNX guiding a sharp Q2 rebound. HTLD has run ~69% in three months to its 52-week high on the recovery and balance-sheet deleveraging, but the…

Medicare Advantage margin-recovery trade: April's final 2027 CMS rate (+2.48%, ~$13B) cleared the overhang and HUM carries the most MA torque. Doubled off $163 to a $350 ATH (2026-06-04) as even bears lift PTs (MS $217→$249, BofA $340) but…

Data-center electrical "shovels" play; Q2 FY26 (2026-05-01) backlog +62% to $3.9B, Communications +35% YoY fundamentals still accelerating. But +37% in a month into the $713.82 ATH with ~$108.6M of insider selling means a fresh entry buys…

Q2 FY26 binary (2026-05-20) resolved bullish all-time-high orders/rev/EPS/FCF and a raised guide, and the sell-side caught up in one week ($350–$425 PT cluster vs ~$200 prior median). The first-mover upgrade edge is now consumed; the…

Gas-compression operator re-rated as a behind-the-meter data-center power play. Q1 (2026-05-11) cleared the binary: record EBITDA $190M, FY guide raised to $820–860M, and a disclosed 650 MW capacity + 1.3 GW pipeline replacing the old 100…

Process-control toll-taker on the AI buildout: custom-silicon design-start proliferation + advanced packaging (>70% YoY) + re-accelerating memory WFE, with FY2026 guided to high-teens growth and 2H acceleration. Narrative is ACCELERATING,…

Freight-cycle inflection accelerating: tightening truckload capacity + bid season targeting mid-to-high-single/double-digit contract increases repricing late Q2 into H2 2026, with KNX the bellwether. Analyst PTs cluster $86–94 vs ~$82…

AI-datacenter MEP pick-and-shovel thesis converted from deck-slides to booked revenue: Q1 (reported 5/14) rev $1.04B +105% YoY, FY guide raised to $4.1–4.3B, record $5.4B backlog booked into late 2028. Stock ran $54 secondary → $107 high,…

Beaten-down broad-line semi re-rating on a freshly disclosed AI-data-center leg: DCS unit +62.9% YoY (Mar-26 qtr), $302.7M CY25 guided to ~$500M CY26 (+65%). But the 06-01 guidance pop (+8%) has round-tripped to the 50-day EMA near $87 a…

Gene-therapy shots-on-goal re-rate has cooled from ACCELERATING to MATURING after the Apr cluster (J&J bota-vec buyback, xerostomia Breakthrough, Hologen up-to-$430M). Stock rolled ~24% off the $11.85 high and on 2026-06-05 closed $9.00,…

AI data-center power narrative still ACCELERATING (Q1 Enterprise Data ~2x YoY to $262.8M; Q2 guide ~$900M midpoint, +35% YoY), but a Feb-26 non-reliance restatement and heavy CEO/insider selling are a fresh overhang. A 10% flush on 6/5 to…

Roll-up compounder confirmed by a record Q1 (reported 2026-05-06: revenue +48% to $692M, adj PBT +59%), with the 2026-06-01 Levmet bolt-on extending a 5-deal-in-12-months cadence. But price has run +39.9% in 90 days to ~$55.89, now at the…

AI/datacenter power-buildout lifting grid electrical contractors; MYRG validated it with a record Q1 (rev $1.0B +20%, EPS $2.99 beat ~45%, backlog $2.84B) and raised FY guide to ~12%. Theme ACCELERATING + cluster-confirmed, but after…

Oncology-diagnostics turnaround accelerating: NGS revenue +26% and the RaDaR ST MRD launch (post-Natera patent win) drove a Q1 beat, a raised FY guide ($797–803M) and an analyst upgrade cluster (Leerink to $25). The leg is real but…

Legacy telecom-equipment maker re-rating as an AI-data-center-networking play: Nvidia's ~$1B stake at $6.01/sh (Oct 2025) plus the 2026-05-21 AI Networking Lab (AMD, Keysight) drove a multi-month run to a 52-week high on 2026-05-26. Theme…

AI-data-center-power re-rate is lifting NXT from solar-tracker picks-and-shovels toward power-infra platform: 2026-05-28 FY2027 guide raise ($4.0-4.4B rev) + $365M Prevalon storage buy + 10-desk PT cluster ($149-182). Theme ACCELERATING,…

Company narrative intact AI data-center power re-rate (NVIDIA 800VDC/MGX content step-up, Q2 guide: AI revenue to double YoY in 2026) but the tape broke: -11.05% to $117.26 on 2026-06-05 in the worst SOX session since March 2020 (Broadcom…

Semicap/advanced-packaging metrology story is intact but the April momentum leg is spent: the 2026-05-05 Q1 came in-line ($292M as pre-announced, EPS $1.42 down YoY) with Q2 guide merely reiterated, and the stock derated ~20% from $316 to…

Legacy regional-casino operator's digital turnaround is inflecting: after exiting the ESPN Bet money-pit (2025-12-01), iCasino NGR ran +362% YoY and the interactive EBITDA loss narrowed to $10.8M from $89M, guidance was raised, and Q4-2026…

800VDC AI-data-center power theme ACCELERATING (Navitas joined NVIDIA MGX 2026-06-03; POWI Kyber aux-PSU designs 2026-06-01), but POWI broke -9.7% on 2026-06-05 in a sector selloff and is now testing the $74-78 May breakout shelf. Shelf…

Wildfire fire-retardant monopoly (PHOS-CHEK) into a peak season running ~195% of the 10-yr acres-burned average the live demand thesis is confirming. Q1 +74% to $125M, ~$1.3B USFS contract retained, $500M DLA foam deal ramping 2027. Price…

Binary resolved bullish: zovegalisib (RLY-2608) posted ~11-mo PFS, won FDA Breakthrough Therapy, and is funded into 2029 sell-side re-rated to $26–$28 (from $18–$21) as shares broke to a 52-wk high $17.33. The leg now is the post-data…

AI memory-interface royalty (DDR5 RCD + HBM4E IP) still compounding double-digit on product, but the parabolic leg topped at $174.10 (2026-06-03) and is rolling ~9% lower to ~$158 by 2026-06-05 amid a COO share sale and a CFO exit. Theme…

KRAS-franchise narrative maturing, not breaking: ASCO-grade RASolute-302 data (daraxonrasib doubles PDAC survival, ~60% death-risk cut), NEJM publication and FDA expanded access have walked analyst PTs into a $182–195 cluster with the…

BNPL super-app reaccelerating: Q1 (5/6) beat with GMV +37.3%, FY26 guide raised to 30-35% rev growth, sell-side now chasing (B. Riley to $141 from $117 on 6/2). Lone fintech leader with no peer cluster; +57.9% in 3mo into a ~2-month…

Beaten-down dividend telecom re-rating into an AI-infrastructure name: Q1 (2026-05-09) AI-datacenter revenue +89% YoY, breach recovery (dividend reinstated, +210k net adds), and Jensen Huang naming SKT a Nvidia "Physical AI" partner at GTC…

Fiscal Q2 (reported 2026-05-06) was a record blowout net operating revenue +70% YoY, net income +143%, ROE 26.5% as the R.J. O'Brien integration made StoneX the largest US non-bank FCM. Trend is strong near 52-week highs ($125 vs ~$115);…

IT-distribution re-rating, not a chip play: a cluster of PT hikes (JPM Overweight $298 on 5/27, BofA $270, UBS $265) drove SNX to a fresh ATH ~$286 on Q1 gross billings +24% YoY. The Q2 print, now pulled forward to 2026-06-25, is the…

Data-center cooling breakout confirmed: SPXC reclaimed its 200-day near $210 and ran to $234 (~5% off the $246.68 high) on the 2026-04-30 beat-and-raise that hiked DC-cooling growth +50%→+70%. Narrative accelerating, but a fresh entry at…

Beaten-down sports-data name re-rating into the data/integrity infrastructure layer for prediction markets after the 2026-06-08 Kalshi deal (Needham PT $19→$23). Theme is accelerating but price sits below all moving averages a narrative…

Data-center site-development narrative accelerating: Q1 revenue +92% to $825.7M, FY26 EPS guide hiked to $16.50-17.15, and a rising analyst PT cluster ($922-956, Keybanc/Oppenheimer/Cantor). Real upgrade cycle, but price is extended ~+50%…

~$6.36 vs $11.35 high. Probe-to-medium; a dilutive raise before 2026-07-31 is the overhang.

Binary PRMT5 catalyst resolved upside: vopimetostat's Oct-2025 Ph1/2 data (27% ORR across 16 tumor types; 2L MTAP-deleted PDAC 25% ORR/7.2mo PFS; FDA-aligned 250mg) de-risked the asset and drove a $3→$28 re-rate. Now ~$20, digesting below…

Rett gene therapy narrative re-rated from clinical binary to BLA execution: FDA aligned on a single-arm pivotal with potential BLA off the REVEAL six-month interim, cash funded into 2028 kills the dilution overhang, and Part A shows 100%…

FILSPARI FSGS launch confirming, not round-tripping: June brought a second target wave (Citi $62, HC Wainwright $67, Wedbush $55), a USPTO patent allowance + Orange Book listing extending exclusivity, and the 2026-06-02 Everest…

Legacy CPaaS repricing as agentic/voice-AI customer-engagement infrastructure; the 2026-06-01 Cowen "turnaround complete" +20% gap has EXTENDED, not faded Tigress $255 (06-11, new Street high) and a BofA "Fab Five" leadership tag (06-10),…

Analog-cyclical recovery re-rating into an AI-data-center-power story (Q1 rev +19%, Data Center +~90% YoY), but TXN-specific easy money is banked: price stalls under the $331.51 ATH, above the ~$289 avg PT, and Wells Fargo's 2026-06-09…

Vector AI ad-engine turnaround still accelerating on fundamentals Strategic Grow +49% YoY Q1, guided +50-52% Q2, Vector ~80% bigger YoY toward $1B run-rate by YE26. But the breakout failed: shares round-tripped the Piper-$40 pop from…

Stale "sleepy ADR" tag broken: UMC re-rated ~3x off its $6.56 low to $21.63 (6/12) as the tape reprices an advanced-node/AI-photonics pivot. Q1 EPS doubled YoY (beat), monthly sales accelerating +10.8%→+17.78%, while sell-side targets…

ZUSDURI launch ramp still accelerating: Q1'26 ZUSDURI revenue $29.2M (+109% QoQ), prescribers 102→256, and the 2026-06-10 Goldman fireside reframed it as $1B+ at <20% penetration. First/only FDA drug for LG-IR-NMIBC. But price is pressing…

Profitable precision-oncology dx compounder with a fresh third leg: the TrueMRD whole-genome MRD test won Medicare coverage (2026-05-15, launched 06-01), stacking on a Q1 beat-and-raise and ASCO OPTIMA/ENZAMET data. But all three binaries…

AI-datacenter power-delivery narrative re-accelerated: 2026-05-26 Q2 guide raised to ~$142M (from ~$126M) on a new IP licensee, book-to-bill >2.0, backlog ~$300.6M. Stock reclaimed the $300 pivot (~$306, 2026-06-12) after a…

Grid-transmission buildout going structural FERC Order 1920 + AI data-center load driving multi-year utility-structure demand; Q1 (~4/21) beat and raised guide confirmed Infrastructure leadership, and the theme flipped ACCELERATING in…

AI storage/memory supercycle validated post-print; sell-side re-rating violently (Citi $405→$685 on 2026-06-02, Barclays $620, WF/Evercore $575). Theme ACCELERATING but mature fastest-growing ETF, Micron +18% to Nasdaq records, first 'AI…

Produced-water midstream re-rate with a now-real lithium leg: Q1'26 record Water Infrastructure revenue ($96.7M) plus a raised FY26 infra-growth guide (25-30% YoY) reframe a cyclical OFS name as contracted infrastructure, while…

Tariff-headwind margin-recovery turnaround pressing a multi-year range high near $51: 2026 China COGS guided <5%, ~$300M FY buyback shrinking the float, Drinkware back to growth and wholesale the best in three years (Q1 reported…

Space-defense vertical-integration roll-up moving from announcement to execution: Tranche 1 Transport Layer satellites shipping (2026-06-05), ALL.SPACE satcom order flow building (2026-06-09), both May acquisitions tracking to a…

MIPLYFFA's generic-cliff risk was just removed to 2041 (Orange Book patent + PTE filing, 2026-06-08), triggering a six-firm PT-raise cluster ($25–35) while the drug's ramp runs +78% YoY. A re-rating of a debt-free, cash-generative…